Behzad Aghazadeh
Director, 10% Owner · Scribe Therapeutics, Inc.
- 2026
- Jul 29, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Behzad Aghazadeh files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Carl L. Gordon - $15.00M in SCTX purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $15.00M in SCTX purchases and sales in the last 12 months
- AH Bio Fund II, L.P. - $5.00M in SCTX purchases and sales in the last 12 months
- David James Lennon - $1.06M in WHWK purchases and sales in the last 12 months
- Scott M. Giacobello - $891K in WHWK purchases and sales in the last 12 months
- Bryan Ball - $635K in WHWK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Behzad Aghazadeh?
Behzad Aghazadeh is a corporate insider, tracked as Director, 10% Owner of Scribe Therapeutics, Inc. (SCTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Behzad Aghazadeh last file a Form 4?
The most recent primary Form 4 on record is dated 29 July 2026, one of 3 filings going back to 2026.
Has Behzad Aghazadeh been buying or selling stock?
Recorded transactions: 3 open-market purchases ($36.26M) and 0 open-market sales across all tracked filings.
